BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25903707)

  • 1. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
    Fischer MA; Kartalis N; Grigoriadis A; Loizou L; Stål P; Leidner B; Aspelin P; Brismar TB
    Eur Radiol; 2015 Nov; 25(11):3123-32. PubMed ID: 25903707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
    Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
    Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
    Lee DH; Lee JM; Klotz E; Han JK
    Invest Radiol; 2016 Jul; 51(7):430-4. PubMed ID: 26756941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-resolved computed tomography of the liver: retrospective, multi-phase image reconstruction derived from volumetric perfusion imaging.
    Fischer MA; Leidner B; Kartalis N; Svensson A; Aspelin P; Albiin N; Brismar TB
    Eur Radiol; 2014 Jan; 24(1):151-61. PubMed ID: 23995880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
    Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
    Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image quality of mean temporal arterial and mean temporal portal venous phase images calculated from low dose dynamic volume perfusion CT datasets in patients with hepatocellular carcinoma and pancreatic cancer.
    Wang X; Henzler T; Gawlitza J; Diehl S; Wilhelm T; Schoenberg SO; Jin ZY; Xue HD; Smakic A
    Eur J Radiol; 2016 Nov; 85(11):2104-2110. PubMed ID: 27776665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.
    Lee DH; Lee JM; Klotz E; Kim SJ; Kim KW; Han JK; Choi BI
    Korean J Radiol; 2013; 14(1):51-60. PubMed ID: 23323031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of 128 slice 4D CT whole liver perfusion imaging in hepatic tumor.
    Guo M; Yu Y
    Cell Biochem Biophys; 2014 Sep; 70(1):173-8. PubMed ID: 24691926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model.
    Li JP; Feng GL; Li DQ; Wang HB; Zhao DL; Wan Y; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):612-618. PubMed ID: 27919850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps.
    Hatzidakis A; Perisinakis K; Kalarakis G; Papadakis A; Savva E; Ippolito D; Karantanas A
    Acta Radiol; 2019 May; 60(5):561-568. PubMed ID: 30114926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
    Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterioportal shunts not directly related to hepatocellular carcinoma: findings on CT during hepatic arteriography, CT arterial portography and dual phase spiral CT.
    Park CM; Cha SH; Kim DH; Choi JA; Cha IH; Kim YH; Chung KB; Suh WH
    Clin Radiol; 2000 Jun; 55(6):465-70. PubMed ID: 10873693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of ultrasonography in the diagnosis and treatment tracing of hepatocellular carcinoma-associated arteriovenous fistulas.
    Li YY; Duan YY; Yan GZ; Lv FQ; Cao W; Cao TS; Yuan LJ
    Liver Int; 2007 Aug; 27(6):869-75. PubMed ID: 17617131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
    World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.